"Receptors, Opioid, mu" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine.
MeSH Number(s)
D12.776.543.750.100.620.550
D12.776.543.750.720.600.610.550
D12.776.543.750.750.555.610.550
Concept/Terms
Receptors, Opioid, mu- Receptors, Opioid, mu
- Opioid Receptors, mu
- mu Opioid Receptors
- Receptors, mu Opioid
- Receptors, mu
- mu Receptor
- Receptor, mu
- mu Receptors
- mu Opioid Receptor
- Opioid Receptor, mu
- Receptor, mu Opioid
Morphine Receptor- Morphine Receptor
- Receptor, Morphine
- Receptors, Morphine
- Morphine Receptors
Below are MeSH descriptors whose meaning is more general than "Receptors, Opioid, mu".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.100]
- Receptors, Opioid [D12.776.543.750.100.620]
- Receptors, Opioid, mu [D12.776.543.750.100.620.550]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Neuropeptide [D12.776.543.750.720.600]
- Receptors, Opioid [D12.776.543.750.720.600.610]
- Receptors, Opioid, mu [D12.776.543.750.720.600.610.550]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Neuropeptide [D12.776.543.750.750.555]
- Receptors, Opioid [D12.776.543.750.750.555.610]
- Receptors, Opioid, mu [D12.776.543.750.750.555.610.550]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Opioid, mu".
This graph shows the total number of publications written about "Receptors, Opioid, mu" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Opioid, mu" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 2 | 3 |
| 1994 | 2 | 1 | 3 |
| 1995 | 2 | 0 | 2 |
| 1996 | 3 | 4 | 7 |
| 1997 | 4 | 1 | 5 |
| 1998 | 3 | 3 | 6 |
| 1999 | 3 | 0 | 3 |
| 2000 | 3 | 1 | 4 |
| 2001 | 1 | 2 | 3 |
| 2002 | 2 | 2 | 4 |
| 2003 | 6 | 3 | 9 |
| 2004 | 2 | 2 | 4 |
| 2005 | 7 | 1 | 8 |
| 2006 | 2 | 3 | 5 |
| 2007 | 2 | 2 | 4 |
| 2008 | 3 | 0 | 3 |
| 2009 | 3 | 3 | 6 |
| 2010 | 3 | 2 | 5 |
| 2011 | 1 | 0 | 1 |
| 2012 | 4 | 2 | 6 |
| 2013 | 5 | 6 | 11 |
| 2014 | 0 | 1 | 1 |
| 2015 | 7 | 0 | 7 |
| 2016 | 1 | 1 | 2 |
| 2017 | 5 | 1 | 6 |
| 2018 | 5 | 2 | 7 |
| 2019 | 3 | 3 | 6 |
| 2020 | 4 | 1 | 5 |
| 2021 | 2 | 1 | 3 |
| 2022 | 0 | 2 | 2 |
Below are the most recent publications written about "Receptors, Opioid, mu" by people in Profiles.
-
A Journey through Diastereomeric Space: The Design, Synthesis, In Vitro and In Vivo Pharmacological Activity, and Molecular Modeling of Novel Potent Diastereomeric MOR Agonists and Antagonists. Molecules. 2022 Sep 30; 27(19).
-
Perioperative Buprenorphine Management: A Multidisciplinary Approach. Med Clin North Am. 2022 Jan; 106(1):169-185.
-
Identification of the Fc-alpha/mu receptor in Xenopus provides insight into the emergence of the poly-Ig receptor (pIgR) and mucosal Ig transport. Eur J Immunol. 2021 11; 51(11):2590-2606.
-
Moving Beyond Medications That Act at the µ Receptor in the Treatment of Opioid Use Disorder. JAMA Psychiatry. 2021 07 01; 78(7):701-702.
-
Recent Advances in the Treatment of Opioid Use Disorder. Curr Pain Headache Rep. 2021 Mar 11; 25(4):23.
-
Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials. Int J Neuropsychopharmacol. 2020 12 03; 23(9):549-558.
-
Dissecting the Role of GABA Neurons in the VTA versus SNr in Opioid Reward. J Neurosci. 2020 11 11; 40(46):8853-8869.
-
Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence. Drug Alcohol Depend. 2020 11 01; 216:108310.
-
Opioid Receptor µ-1 and Ketamine Effects in a Suicidal Depression Trial: A Post Hoc Exploration. J Clin Psychopharmacol. 2020 Jul/Aug; 40(4):420-422.
-
The Intriguing Effects of Substituents in the N-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments. Molecules. 2020 Jun 06; 25(11).